HGF/c-Met comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-01-10. Where a claim depends on a specific study, the study is described rather than over-claimed.
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
Analytical confirmation generally combines a separation method with a detection method. Reverse-phase high-performance liquid chromatography can assess purity, while mass spectrometry supports molecular identity. For research-grade material, a certificate of analysis may report a batch-specific purity value, but it does not guarantee biological activity or safety. Regulatory frameworks vary by country; many jurisdictions treat dihexa as a research chemical not intended for human consumption. Purchasers should verify local rules and supplier documentation. The absence of official standards makes independent testing and careful record-keeping important for laboratory work.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for lyophilized peptide-like research chemicals. |
| Solubility | Limited in water; soluble in some organic solvents | DMSO is commonly used for stock solutions. |
| Typical storage | -20 °C or below, desiccated, protected from light | Avoid repeated freeze-thaw cycles. |
| Purity assessment | Reverse-phase HPLC with UV detection | Mass spectrometry is often used for identity confirmation. |
| Common document | Certificate of analysis | Batch-specific; does not establish safety or efficacy. |
Research interest in dihexa centers on its ability to promote synapse formation in cultured neurons and in some rodent experiments. These findings have been interpreted as a possible mechanism for learning and memory effects, but the evidence remains preliminary. Independent replication is limited, and study designs vary widely in species, duration, and outcome measures. Human data are scarce, so claims about cognitive enhancement in people are not supported by robust clinical evidence. The gap between laboratory signals and proven clinical benefit is substantial.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
== Career == While attending the University of Hawaiʻi, Nickson was a model in Honolulu, where she appeared in her first play, The Winter's Tale. After acting classes, community theater, and roles on Magnum, P.I., she appeared as the female lead in Rambo: First Blood Part II (1985). She appeared with Chuck Norris in Sidekicks (1992). Her other film appearances have included roles in Glitch! (1988), China Cry (1991), K2 (1992), Double Dragon (1994), White Tiger (1996), Devil in the Flesh (1998), Ethan Mao (2004), Half-Life (2008), Dim Sum Funeral (2008), and One Kine Day (2011). Nickson guest starred in the final episode of seaQuest 2032 as Lieutenant Commander Heiko Kimura, a role that would have been a main character had the series continued, and in two Star Trek series: The Next Generation episode "The Arsenal of Freedom" as Enterprise-D crewmember Ensign Lian T'su, and the Deep Space Nine episode "Paradise" as Cassandra, a villager who attempts to seduce Commander Benjamin Sisko. She played Catherine Sakai, Commander Jeffrey Sinclair's love-interest, in the first season of Babylon 5. She had a recurring role as Dr. Susan Lee on the television series Walker, Texas Ranger (reuniting her with Chuck Norris), and as Princess Aouda in the 1989 miniseries version of Around the World in 80 Days opposite Pierce Brosnan and Eric Idle. She had a supporting role in the television version of the novel Noble House, again opposite Brosnan. Julia retired from acting for personal reasons on March 29, 2025
== Interactions == LRP5 has been shown to interact with AXIN1. Canonical WNT signals are transduced through Frizzled receptor and LRP5/LRP6 coreceptor to downregulate GSK3beta (GSK3B) activity not depending on Ser-9 phosphorylation. Reduction of canonical Wnt signals upon depletion of LRP5 and LRP6 results in p120-catenin degradation.
18 February 1919: In spite of the ceasefire, there is fighting near Rynarzewo. The Poles capture the armoured train. 9 February 1919: A volunteer company of Great Polish soldiers moves to Lesser Poland to fight against the Ukrainians. 20 March 1919: The Ostmarkenzulage, a special allowance for German officials working in the eastern provinces to stimulate the German colonization of the Prussian Partition, is canceled. 23 March 1919: The Poles win a landslide in elections to the city council of Poznań. 24 March 1919: The Commission of the NRL asks the Polish government in Warsaw to create separate administration of the former Prussian Partition, as it is far more developed than the rest of the country. Ignacy Paderewski forces the government to leave all power in hands of the NRL until the final recognition of Polish-German border, with later autonomy there (only Upper Silesia would obtain it). The NRL mobilises men born in 1891, 1892, 1893, 1894 and 1901. 5 April 1919: The Sejm Ustawodawczy announces byelections in the former Province of Posen for next 42 MPs. 9 April 1919: The Commission of the NRL decrees an eight-hour workday in industry and trade. 10 April 1919: The Commission of the NRL decrees the removal of signs in German language from offices and train stations the changing of all streets names into Polish. The punishment for breaking the law is two years of prison and a fine of Mp. 10,000. 16 April 1919: The NRL decides that 3 May is the national holiday. 7 May 1919: The Wszechnica Piastowska is opened. 15 May 1919: Polish becomes the only official language.
Causes: (a) Microvesicular: Aspirin (Reye's syndrome), ketoprofen, tetracycline (especially if expired) (b) Macrovesicular: Acetaminophen, methotrexate (c) Phospholipidosis: Amiodarone, total parenteral nutrition (d) Antiviral: nucleoside analogues (e) Corticosteroid (f) Hormonal: Tamoxifen
During the bidding process, 41 cities with 42 existing, fully functional venues with regular tenants (except Olympic Stadium in Montreal) and two venues then under construction (Allegiant Stadium in Las Vegas and SoFi Stadium in Los Angeles) submitted to be part of the bid: three venues in three cities in Mexico, six venues in six cities in Canada, and 35 venues in 32 cities in the United States. A first-round elimination removed nine venues and nine cities. A second-round elimination cut an additional nine venues in six cities, while three venues in three cities (Soldier Field in Chicago, U.S. Bank Stadium in Minneapolis, and BC Place in Vancouver) dropped out because FIFA was unwilling to negotiate financial details. After Montreal dropped out in July 2021 because it lacked provincial funding and support to renovate Olympic Stadium, Vancouver rejoined the bid as a candidate city in April 2022, bringing the total number to 24 venues, each in its own city or metropolitan area. On June 16, 2022, the sixteen host cities–two in Canada, three in Mexico, and eleven in the United States–were announced by FIFA: Atlanta, Boston, Dallas, Guadalajara, Houston, Kansas City, Los Angeles, Mexico City, Miami, Monterrey, New York/New Jersey, Philadelphia, San Francisco Bay Area, Seattle, Toronto, and Vancouver. Eight of the sixteen chosen stadiums had permanent artificial turf surfaces that were replaced with grass under the direction of FIFA and a University of Tennessee–Michigan State University research team.
Sources: en.wikipedia.org
== Research career and academic posts == After completing graduate school, Fenn's first job was with Monsanto, working in the Phosphate Division and producing polychlorinated biphenyls (PCBs). Fenn and his colleague James Mullen became disenchanted with the direction of work at Monsanto, and they resigned together in 1943. Fenn worked briefly at a small company named Sharples Chemicals that focused on the production of amyl chloride derivatives. In 1945, he joined Mullen at his new startup, Experiment, Inc, focusing on research and development. Fenn's first publication came in 1949 as a result of his work with Mullen. That this publication came ten years after he completed graduate school made Fenn somewhat of a rarity amongst academics. In 1952, Fenn moved to Princeton University as Director of Project SQUID, a program to support research related to jet propulsion that was funded by the Office of Naval Research. During this period, Fenn started his work developing supersonic atomic and molecular beam sources, which are now widely used in chemical physics research. After working with Project SQUID, Fenn returned to Yale University in 1967. He held a joint appointment in the chemistry and engineering departments until 1987, conducting much of his research in Mason Laboratory. In 1987, Fenn had reached Yale's mandatory retirement age. He became a professor emeritus, entitling him to office space at the university, but costing him most of his laboratory space and research assistants.
Eventually the funk project broke up, and in 1987 Staley joined Cantrell's band on a full-time basis. Two weeks after the band's formation, they were playing a gig at Washington State University, trying to fill in a 40-minute set with a couple of original songs along with Hanoi Rocks and David Bowie covers. The band played a couple of gigs in clubs around the Pacific Northwest, calling themselves different monikers, including Diamond Lie, the name of Cantrell's previous band, and "Fuck", before eventually adopting the name that Staley's previous band had initially flirted with, Alice in Chains. Staley contacted his former bandmates and asked for permission to use the name. Nick Pollock was not particularly thrilled about it at the time, and thought he should come up with a different name; both he and James Bergstrom ultimately gave Staley their blessing to use the name.
By 1982, the perceived passivity of the FARC, together with the relative success of the government's efforts against the M-19 and the ELN, enabled the administration of the Liberal Party's Julio César Turbay Ayala (1978–82) to lift a state-of-siege decree that had been in effect, on and off, for most of the previous 30 years. Under the latest such decree, President Turbay had implemented security policies that, though of some military value against the M-19 in particular, were considered highly questionable both inside and outside Colombian circles due to numerous accusations of military human rights abuses against suspects and captured guerrillas. Citizen exhaustion due to the conflict's newfound intensity led to the election of President Belisario Betancur (1982–1986), a Conservative, with 47% of the popular vote. Betancur directed peace feelers at all the insurgents and negotiated a 1984 cease-fire with the FARC at La Uribe, Meta, after a 1982 release of many guerrillas imprisoned during the previous effort to overpower them. A truce was also arranged with the M-19. The ELN, however, rejected any negotiations and continued to rebuild through the use of extortion and threats, in particular against oil companies of European and U.S. origin. At the same time as these developments, the growing illegal drug trade was becoming increasingly important to all participants in the Colombian conflict. Guerrillas and newly wealthy drug lords had mutually uneven relations, and numerous incidents occurred between them.
== Treatment == The current simplest treatment for elevated Lp(a) is to take 1–3 grams of niacin daily, typically in an extended-release form. Niacin therapy may reduce Lp(a) levels by 20–30%. However more recent research suggests that the inflammatory effects of the breakdown products of excess niacin lead to an increase in risk of major adverse cardiovascular event. A meta-analysis suggested that atorvastatin may lower Lp(a) levels. In severe cases, such as familial hypercholesterolemia or treatment-resistant hypercholesterolemia, LDL apheresis may dramatically reduce Lp(a). The goal of the treatment is to reduce levels to below 50 mg/dL. Cost is prohibitively high. PCSK9 inhibitors lower Lp(a). In the CORALreef Lipids trial, enlicitide reduced Lp(a) by 28%. Four medications are in clinical trials to lower Lp(a), including pelacarsen (80% reduction), olpasiran (95% reduction), lepodisiran (94% reduction), and muvalapin (47-86% reduction). A meta-analysis of six clinical trials confirmed that flaxseed supplementation modestly lowers Lp(a) levels. Testosterone is known to reduce Lp(a) levels. Testosterone replacement therapy also appears to be associated with lower Lp(a) levels. Estrogen replacement therapy in post-menopausal women will reduce Lp(a). Raloxifene has not been shown to reduce Lp(a), while tamoxifen has. L-carnitine may also reduce Lp(a) levels. A systematic review and meta-analysis found a significant reduction with oral but not intravenous carnitine.
Sources: en.wikipedia.org
Dry powder is usually kept frozen, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data for dihexa are limited, so general peptide storage practices are commonly used.
Reverse-phase HPLC is commonly used to estimate purity, and mass spectrometry helps confirm molecular identity. Certificates of analysis may summarize these results. Independent testing can provide additional verification when standards are unavailable.
In many countries, dihexa is not approved as a medicine and is sold only for research purposes. Regulations differ by jurisdiction, and import or possession rules may apply. Buyers should confirm local legal status before obtaining it.
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.